Literature DB >> 18780081

Revised Tubiana's staging system for assessment of disease severity in Dupuytren's disease-preliminary clinical findings.

Sandip Hindocha1, John K Stanley, James Stewart Watson, Ardeshir Bayat.   

Abstract

There are few objective staging systems to assess severity of Dupuytren's disease (DD). Previous methods to assess severity of DD were based primarily on the degree of contracture of an affected digit measured using a goniometer. Nonetheless, this method of assessment alone may be incomplete, and other factors should be considered. White (n = 92) patients diagnosed with DD from northwest of England were assessed for DD. Objective criteria for evaluating severity incorporated quantified variables. The revised severity stage was correlated to a known staging system of DD (Tubiana's staging system) which measures total flexion deformity for a single affected digit. Total revised severity staging scores ranged between 4 and 53 (mean = 18.7) and revealed significant positive correlation to Tubiana's original staging system (r (2) = 0.8, p < 0.001). There was significant difference between severity staging scores in those with a positive family history compared to those without (p < 0.01). In current practice, often, the degree of contracture in an affected digit is used solely as a measure of disease severity. Additional objective clinical information may provide useful prognostic indices for disease progression as well as postoperative outcome.

Entities:  

Year:  2007        PMID: 18780081      PMCID: PMC2529142          DOI: 10.1007/s11552-007-9071-1

Source DB:  PubMed          Journal:  Hand (N Y)        ISSN: 1558-9447


  26 in total

1.  Dupuytren's disease in type 1 diabetic patients: a five-year prospective study.

Authors:  P E Arkkila; I M Kantola; J S Viikari; T Rönnemaa; M A Vähätalo
Journal:  Clin Exp Rheumatol       Date:  1996 Jan-Feb       Impact factor: 4.473

2.  The association between alcohol, hepatic pathology and Dupuytren's disease.

Authors:  J Noble; M Arafa; S G Royle; G McGeorge; S Crank
Journal:  J Hand Surg Br       Date:  1992-02

3.  Responsiveness of the Michigan Hand Outcomes Questionnaire and physical measurements in outcome studies of distal radius fracture treatment.

Authors:  Sandra V Kotsis; Frank H Lau; Kevin C Chung
Journal:  J Hand Surg Am       Date:  2007-01       Impact factor: 2.230

4.  Dupuytren's disease--initial symptoms, age of onset and spontaneous course.

Authors:  O A Mikkelsen
Journal:  Hand       Date:  1977-02

Review 5.  Dupuytren's disease.

Authors:  Alan J Thurston
Journal:  J Bone Joint Surg Br       Date:  2003-05

6.  The incidence of Dupuytren's disease in patients with rheumatoid arthritis.

Authors:  M Arafa; R F Steingold; J Noble
Journal:  J Hand Surg Br       Date:  1984-06

7.  Smoking, alcohol and the risk of Dupuytren's contracture.

Authors:  P Burge; G Hoy; P Regan; R Milne
Journal:  J Bone Joint Surg Br       Date:  1997-03

Review 8.  Diagnosis and indications for surgical treatment.

Authors:  A C Smith
Journal:  Hand Clin       Date:  1991-11       Impact factor: 1.907

9.  The heritability of Dupuytren's disease: familial aggregation and its clinical significance.

Authors:  Sandip Hindocha; Sally John; John K Stanley; Stewart J Watson; Ardeshir Bayat
Journal:  J Hand Surg Am       Date:  2006-02       Impact factor: 2.230

10.  A clinical grading system for Dupuytren's contracture.

Authors:  M J Woodruff; M A Waldram
Journal:  J Hand Surg Br       Date:  1998-06
View more
  7 in total

1.  Increased CCT-eta expression is a marker of latent and active disease and a modulator of fibroblast contractility in Dupuytren's contracture.

Authors:  Latha Satish; David B O'Gorman; Sandra Johnson; Christina Raykha; Bing Siang Gan; James H-C Wang; Sandeep Kathju
Journal:  Cell Stress Chaperones       Date:  2013-01-06       Impact factor: 3.667

Review 2.  Scientific understanding and clinical management of Dupuytren disease.

Authors:  Barbara Shih; Ardeshir Bayat
Journal:  Nat Rev Rheumatol       Date:  2010-11-09       Impact factor: 20.543

Review 3.  Dupuytren's Disease: An Outcomes-Focused Update.

Authors:  Yasser H Almadani; Joshua Vorstenbosch; Johnny Ionut Efanov; Liqin Xu
Journal:  Semin Plast Surg       Date:  2021-07-06       Impact factor: 2.195

4.  Differential gene expression analysis of subcutaneous fat, fascia, and skin overlying a Dupuytren's disease nodule in comparison to control tissue.

Authors:  Barbara Shih; Jason J Brown; Daniel J Armstrong; Tommy Lindau; Ardeshir Bayat
Journal:  Hand (N Y)       Date:  2009-01-29

5.  Visual Estimation of Dupuytren's Flexion Contractures-A Prospective Comparative Trial.

Authors:  Joseph P Corkum; Joshua A Gillis; David T Tang
Journal:  Plast Surg (Oakv)       Date:  2018-01-09       Impact factor: 0.947

6.  Reversal of TGF-β1 stimulation of α-smooth muscle actin and extracellular matrix components by cyclic AMP in Dupuytren's-derived fibroblasts.

Authors:  Latha Satish; Phillip H Gallo; Mark E Baratz; Sandra Johnson; Sandeep Kathju
Journal:  BMC Musculoskelet Disord       Date:  2011-05-25       Impact factor: 2.362

7.  Assessment of palmar subcutaneous tissue vascularization in patients with Dupuytren's contracture.

Authors:  Nathalia Shchudlo; Tatyana Varsegova; Tatyana Stupina; Tamara Dolganova; Michael Shchudlo; Nathalia Shihaleva; Vadim Kostin
Journal:  World J Orthop       Date:  2018-09-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.